THE SINGLE BEST STRATEGY TO USE FOR MBL77

Not all clients with CLL require therapy. Irrespective of all recent innovations, the iwCLL nonetheless recommends watchful observation for sufferers with asymptomatic illness.86 This suggestion is based on no less than two randomized trials comparing observation to both chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR).